EP3268493
Heilblóðbundið mRNA markefni til að segja fyrir um blöðruhálskirtilskrabbamein og aðferðir til að greina það
:
EP Einkaleyfi fallið úr gildi:
11.3.2016:
5.1.2022:
16713202.6
:
15.2.2022:
15.3.2022
:
10.3.2036:
10.3.2023
:
WHOLE BLOOD BASED MRNA MARKERS FOR PREDICTING PROSTATE CANCER AND METHODS OF DETECTING THE SAME
11.3.2016
5.1.2022
15.2.2022
15.3.2022
10.3.2023
:
Janssen Pharmaceutica NV:
Turnhoutseweg 30, 2340 Beerse, BE
:
RICCI, Deborah:
Raritan, New Jersey 08869, US
:
GORMLEY, Michael:
Spring House, Pennsylvania 19477, US
:
THOMAS, Shibu:
Spring House, Pennsylvania 19477, US
:
RAJPUROHIT, Yashoda:
Spring House, Pennsylvania 19477, US
:
SCHAFFER, Michael:
Spring House, Pennsylvania 19477, US
:
Árnason Faktor ehf.:
Guðríðarstíg 2-4, 113, Reykjavík,
:
201562132064 P:
12.3.2015:
US
:
US2016022004:
11.3.2016
:
C12Q 1/6886
: 7
: 8.2.2022
: 10.3.2023
: Árnason Faktor ehf.